Thailand is the latest country to join Italy, Denmark and several other European countries in suspending the use of AstraZeneca Plc’s COVID-19 vaccine, citing safety concerns after being reported that the vaccine triggers blood clots.
The Asian nation is the first non-European country to suspend the use of the AstraZeneca shot. Denmark was the first to announce suspension of the vaccine following reports of “serious cases of blood clots” among people who had received the shot earlier this month.
Austria, on Monday, announced that it was suspending the use of AstraZeneca vaccines after a 49-year-old nurse died of “severe blood coagulation problems” just days after receiving the shot.
Denmark, Iceland, Norway, Estonia, Latvia, Lithuania and Luxemburg have also suspended the use of the vaccine from the batch, which was shipped to 17 European countries and consisted of one million anti-Covid jabs.
It is the latest setback for the vaccine amidst confusion around its initial study results and delayed deliveries in Europe, which fueled a dispute with the UK.
However, AstraZeneca said it had not found any evidence of an increased risk of pulmonary embolism or deep vein thrombosis (marked by the formation of blood clots) in safety data of more than 10 million records, even when considering subgroups based on age, gender, production batch or country of use. More than 11 million doses of AstraZeneca’s vaccine have been administered so far.
- Bengaluru FC beat gritty Army Green 3-2 to enter Durand Cup semifinals
- Assam claims PFI behind police-peasant conflict in Sipajhar
- Arunachal will benefit most from oil palm cultivation: Khandu
- Legislature needs to revisit laws to suit ‘practical realities’: CJI
- Cong questions Shah’s silence over Assam border row, Sipajhar
- Under Taliban, thriving Afghan music scene heads to silence